IDEAYA Prepares for AACR 2025 Presentation Focused on Innovative Cancer Treatments with IDE275 (GSK959) IDEAYA Biosciences gears up for AACR 2025, showcasing IDE275 (GSK959) for MSI-H cancers, revealing promising results and collaboration details.

IDEAYA Prepares for AACR 2025 Presentation Focused on Innovative Cancer Treatments with IDE275 (GSK959) #United_States #Chicago #Cancer_Research #IDEAYA #GSK959